Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses

The intestinal immune and inflammatory responses of Norovirus (NoV) are poorly defined. The objective of this study was to investigate fecal cytokine and lactoferrin profiles in response to NoV gastroenteritis in travelers. Both fecal cytokines and fecal lactoferrin were measured for NoV‐associated diarrhea (N = 7), mixed infection of NoV and enterotoxigenic E. coli (ETEC)‐associated diarrhea (N = 10) and in pathogen‐negative diarrhea cases (N = 19). Both IL‐2 and IFN‐γ were significantly increased in NoV‐associated diarrhea specimens, suggesting a predominant Th1 immune response to NoV infection in the gut. When a mixed infection of NoV and ETEC occurred, a combined Th1/Th2 response was observed suggesting a dual immune response secondary to infection by both pathogens. Intestinal inflammation associated with increased fecal lactoferrin, important in bacterial enteric infection, was not found in NoV‐associated gastroenteritis. J. Med. Virol. 78:825–828, 2006. © 2006 Wiley‐Liss, Inc.

[1]  A. M. Hutson,et al.  Identification of Genogroup I and Genogroup II Broadly Reactive Epitopes on the Norovirus Capsid , 2005, Journal of Virology.

[2]  R. Baric,et al.  Cellular and Humoral Immunity following Snow Mountain Virus Challenge , 2005, Journal of Virology.

[3]  T. Oka,et al.  Coexistence of Multiple Genotypes, Including Newly Identified Genotypes, in Outbreaks of Gastroenteritis Due to Norovirus in Japan , 2004, Journal of Clinical Microbiology.

[4]  Sudhir Kumar,et al.  MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment , 2004, Briefings Bioinform..

[5]  J. Vinjé,et al.  Development and application of a capsid VP1 (region D) based reverse transcription PCR assay for genotyping of genogroup I and II noroviruses. , 2004, Journal of virological methods.

[6]  E. Kohli,et al.  Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses. , 2004, Vaccine.

[7]  C. Tacket,et al.  Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. , 2003, Clinical immunology.

[8]  M. Altaye,et al.  Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. , 2003, The Journal of infectious diseases.

[9]  Roger I Glass,et al.  Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. , 2002, The Journal of infectious diseases.

[10]  D. Graham,et al.  Norwalk virus infection and disease is associated with ABO histo-blood group type. , 2002, The Journal of infectious diseases.

[11]  H. Dupont,et al.  Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. , 2002, The Journal of infectious diseases.

[12]  B. Lowe,et al.  Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). , 2002, The Journal of infectious diseases.

[13]  S. Fukushi,et al.  Genogroup-specific PCR primers for detection of Norwalk-like viruses. , 2002, Journal of virological methods.

[14]  Z. Jiang,et al.  Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  B. Lowe,et al.  Risk and aetiology of diarrhoea at various tourist destinations , 2000, The Lancet.

[16]  R. Guerrant,et al.  To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea , 1996, Journal of clinical microbiology.

[17]  H. Greenberg,et al.  Serological responses among teenagers after natural exposure to Norwalk virus. , 1984, The Journal of infectious diseases.

[18]  A. Kapikian,et al.  Clinical immunity in acute gastroenteritis caused by Norwalk agent. , 1977, The New England journal of medicine.

[19]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[20]  H. Dupont,et al.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. , 1990, The Journal of infectious diseases.